Giuseppe Palmieri
About
In The Last Decade
Giuseppe Palmieri
249 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 3.1k
- Molecular Biology 3.0k
- Cancer Research 1.2k
- Immunology 1.0k
- Pulmonary and Respiratory Medicine 758
Countries citing papers authored by Giuseppe Palmieri
This map shows the geographic impact of Giuseppe Palmieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Palmieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Palmieri more than expected).
Fields of papers citing papers by Giuseppe Palmieri
This network shows the impact of papers produced by Giuseppe Palmieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Palmieri. The network helps show where Giuseppe Palmieri may publish in the future.
Co-authorship network of co-authors of Giuseppe Palmieri
This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Palmieri. A scholar is included among the top collaborators of Giuseppe Palmieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Palmieri. Giuseppe Palmieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 14 | |
| 3 | 17 | |
| 4 | 99 | |
| 5 | 13 | |
| 6 | 35 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab breakdown → | 351 |
| 10 | 20 | |
| 11 | 30 | |
| 12 | 6 | |
| 13 | 12 | |
| 14 | 13 | |
| 15 | Colorectal cancer epidemiology in an area with a spontaneous screening program | 5 |
| 16 | 360 | |
| 17 | 1 | |
| 18 | 202 | |
| 19 | Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer | 18 |
| 20 | Physical and genetic mapping of polymorphic loci in Xq28 (DXS15, DXS52, and DXS134): analysis of a cosmid clone and a yeast artificial chromosome. | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.